Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor |
Boston,... meht gnidne stroppus yelaeH .vCash... sruoh 2 rof tnemetats sdrocerMKR... hsid yreve gnisicitirc retfa ’Metaplanet... reve yub tseggib-dn2 ni nioctiNottingham... egnellahc ytiC retsehcnaM retfResearchers... sdnaH ruoY htiW etalupinaM naCControl's... emong live na dna edargpu topaTuesday... snoom nwonk tsellams eht fo enErin... dlot yruj ,tsilaiceps noitamroOntario... erac lacidem CTL eesrevo ot sr